96 related articles for article (PubMed ID: 8127659)
1. The reversible DNA-alkylating activity of duocarmycin and its analogues.
Asai A; Nagamura S; Saito H; Takahashi I; Nakano H
Nucleic Acids Res; 1994 Jan; 22(1):88-93. PubMed ID: 8127659
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells.
Okamoto A; Asai A; Saito H; Okabe M; Gomi K
Jpn J Cancer Res; 1994 Dec; 85(12):1304-11. PubMed ID: 7852193
[TBL] [Abstract][Full Text] [Related]
3. A powerful selection assay for mixture libraries of DNA alkylating agents.
Ham YW; Boger DL
J Am Chem Soc; 2004 Aug; 126(30):9194-5. PubMed ID: 15281804
[TBL] [Abstract][Full Text] [Related]
4. Sequence-selective guanine reactivity by duocarmycin A.
Mitchell MA; Weiland KL; Aristoff PA; Johnson PD; Dooley TP
Chem Res Toxicol; 1993; 6(4):421-4. PubMed ID: 8374036
[TBL] [Abstract][Full Text] [Related]
5. Duocarmycins, new antitumor antibiotics produced by Streptomyces; producing organisms and improved production.
Ichimura M; Ogawa T; Katsumata S; Takahashi K; Takahashi I; Nakano H
J Antibiot (Tokyo); 1991 Oct; 44(10):1045-53. PubMed ID: 1955385
[TBL] [Abstract][Full Text] [Related]
6. Interconversion and stability of duocarmycins, a new family of antitumor antibiotics: correlation to their cytotoxic and antimicrobial activities in vitro.
Ichimura M; Ogawa T; Takahashi K; Mihara A; Takahashi I; Nakano H
Oncol Res; 1993; 5(4-5):165-71. PubMed ID: 8305742
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole analogues of duocarmycin B2.
Nagamura S; Kobayashi E; Gomi K; Saito H
Bioorg Med Chem; 1996 Aug; 4(8):1379-91. PubMed ID: 8879561
[TBL] [Abstract][Full Text] [Related]
8. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
Boger DL; Johnson DS
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
[TBL] [Abstract][Full Text] [Related]
9. The two faces of potent antitumor duocarmycin-based drugs: a structural dissection reveals disparate motifs for DNA versus aldehyde dehydrogenase 1 affinity.
Wirth T; Pestel GF; Ganal V; Kirmeier T; Schuberth I; Rein T; Tietze LF; Sieber SA
Angew Chem Int Ed Engl; 2013 Jul; 52(27):6921-5. PubMed ID: 23681547
[No Abstract] [Full Text] [Related]
10. Site specific covalent alkylation of DNA by antitumor antibiotics, duocarmycin A and kapurimycin A3.
Sugiyama H; Lam CK; Hosoda M; Saito I
Nucleic Acids Symp Ser; 1991; (25):75-6. PubMed ID: 1842103
[TBL] [Abstract][Full Text] [Related]
11. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of duocarmycin derivatives.
Nagamura S; Kanda Y; Kobayashi E; Gomi K; Saito H
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1530-5. PubMed ID: 7586077
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the covalent duocarmycin A-DNA duplex complex.
Lin CH; Patel DJ
J Mol Biol; 1995 Apr; 248(1):162-79. PubMed ID: 7731041
[TBL] [Abstract][Full Text] [Related]
14. Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.
Gomi K; Kobayashi E; Miyoshi K; Ashizawa T; Okamoto A; Ogawa T; Katsumata S; Mihara A; Okabe M; Hirata T
Jpn J Cancer Res; 1992 Jan; 83(1):113-20. PubMed ID: 1544867
[TBL] [Abstract][Full Text] [Related]
15. Nucleosome Assembly Alters the Accessibility of the Antitumor Agent Duocarmycin B2 to Duplex DNA.
Zou T; Kizaki S; Pandian GN; Sugiyama H
Chemistry; 2016 Jun; 22(26):8756-8. PubMed ID: 27123891
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
[TBL] [Abstract][Full Text] [Related]
17. Cooperative alkylation by duocarmycin A-distamycin A heterodimer.
Ozeki Y; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1997; (37):91-2. PubMed ID: 9586014
[TBL] [Abstract][Full Text] [Related]
18. High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.
Eis PS; Smith JA; Rydzewski JM; Case DA; Boger DL; Chazin WJ
J Mol Biol; 1997 Sep; 272(2):237-52. PubMed ID: 9299351
[TBL] [Abstract][Full Text] [Related]
19. Analysis of DNA fragmentation in human uterine cervix carcinoma HeLa S3 cells treated with duocarmycins or other antitumor agents by pulse field gel electrophoresis.
Okamoto A; Okabe M; Gomi K
Jpn J Cancer Res; 1993 Jan; 84(1):93-8. PubMed ID: 8449832
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
